ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 157

Chondrocytes Influence Fibroblast-like Synoviocytes from Patients with Juvenile Idiopathic Arthritis, Through the Abrogation of BMP Signaling, to Delay Cell Differentiation and Maturation

Megan Simonds 1, Amanda Schlefman 2, Kathleen Sullivan 3, Carlos Rose 4 and AnneMarie Brescia5, 1Nemours Biomedical Research, Wilmington, 2Johns Hopkins Rheumatology, ST PETERSBURG, Florida, 3The Children's Hospital of Philadelphia, Philadelphia, 4Thomas Jefferson University/duPont Hospital for Children, Wilmington, 5Nemours/ Alfred I duPont Hospital for Children, Wilmington

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Cell Signaling, chondrocytes, Fibroblasts, Juvenile Arthritis, synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) progression leads to growth disturbances in affected joints. Fibroblast-like synoviocytes (FLS) play a key role in JIA pathogenesis; however, the communication mechanisms between FLS and growth plate chondrocytes is not well described. Previously, we showed that JIA FLS overexpress BMP4, promoting chondrocyte hypertrophy [1, 2]. Here, we examine chondrocytes (Ch) influence on diseased FLS to interrogate its effect on bony overgrowth seen in JIA.

Methods: Cell media supernatants were collected from three control FLS (CFLS) and three JIA FLS (JFLS) cell lines at 6, 12, and 24 h. Additionally, media supernatants were collected from three CFLS and three JFLS cell lines cultured in Ch-conditioned media (CFLS-Ch and JFLS-Ch) at 6, 12, and 24 h. ELISA was performed on these samples and protein amount was calculated using protein standards.

Results: Noggin, a potent inhibitor of BMP signaling, expression decreases in JFLS cultured in Ch-conditioned media compared to JFLS (Fig1A). Chordin, a negative regulator of Ch maturation, is overexpressed in JFLS compared to CFLS (Fig1B). Gremlin and Follistatin, both of which are normally expressed at low levels during chondrogenesis, are downregulated in JFLS-Ch compared to JFLS (Fig1C and D). There were no significant changes in collagen II (COL2), a marker of chondroprogenitor cells, expression when FLS were cultured in Ch-conditioned media (Fig2A). Expression of collagen X (COLX), a hypertrophic Ch marker, decreases in JFLS-Ch when compared to JFLS and CFLS-Ch (Fig2B). JFLS-Ch increased expression of Alkaline Phosphatase (ALP), a marker secreted by hypertrophic Ch and osteoblasts, when compared to untreated JFLS (Fig2C).

Conclusion: BMPs play an important role in bone growth. We previously reported that JFLS overexpress BMP4, a member of the TGFβ superfamily that is central to chondrogenesis. Ch influences JFLS to downregulate expression of BMP antagonists, suggesting that Ch have mechanisms that delay cell maturation. Interestingly, JFLS-Ch decreased expression of COLX, a marker of chondrocyte hypertrophy, indicating that Ch influence JFLS to remain in a proliferative state. Other studies showed that bone-type ALP derived from the synovium and synovial fluid of RA patients can contribute to increased diseased activity [3]. Our data reveals that, specifically, JFLS express ALP, a novel finding. We also demonstrate that, although JFLS are primed to follow chondrocyte differentiation path, their progression is delayed via abrogation of BMP signaling when influenced by Ch and may contribute to the bony overgrowth seen in JIA affected joints.

Figure 1. Protein expression of BMP antagonists. Using ELISA, it was determined that noggin significantly decreases in expression when JFLS are treated with Ch_conditioned media (A). Chordin expression significantly increases in JFLS compared to CFLS but is downregulated in JFLS_Ch when compared to untreated JFLS (B). Both gremlin and follistatin are significantly downregulated in JFLS cultured in Ch_conditioned media when compared to untreated Ch (C and D).

Figure 2. Protein expression of chondrocyte differentiation markers. Using ELISA to detect protein quantities, there were no detectable signifcant differences in COL2 expression. COLX is downregulated in JFLS_Ch when compared to untreated JFLS and significantly decreases in JFLS_Ch compared to CFLS cultured in Ch_conditioned media (B). JFLS cultured in Ch_conditioned media significantly overexpress ALP when compared to untreated JFLS (C).


Disclosure: M. Simonds, None; A. Schlefman, None; K. Sullivan, Immune deficiency foundation, 1, UpToDate, 1, Elsevier, 1; C. Rose, None; A. Brescia, None.

To cite this abstract in AMA style:

Simonds M, Schlefman A, Sullivan K, Rose C, Brescia A. Chondrocytes Influence Fibroblast-like Synoviocytes from Patients with Juvenile Idiopathic Arthritis, Through the Abrogation of BMP Signaling, to Delay Cell Differentiation and Maturation [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/chondrocytes-influence-fibroblast-like-synoviocytes-from-patients-with-juvenile-idiopathic-arthritis-through-the-abrogation-of-bmp-signaling-to-delay-cell-differentiation-and-maturation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chondrocytes-influence-fibroblast-like-synoviocytes-from-patients-with-juvenile-idiopathic-arthritis-through-the-abrogation-of-bmp-signaling-to-delay-cell-differentiation-and-maturation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology